The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Gastrografin
diatrizoate meglumine and diatrizoate sodium · DIATRIZOATE MEGLUMINE 660 mg/mL; DIATRIZOATE SODIUM 100 mg/mL · Liquid · Oral; Rectal · Bracco Diagnostics Inc
NDC 00270-0445-35 · 24 BOTTLE in 1 BOX / 30 mL in 1 BOTTLE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Medicare Part B (ASP)
Payment limit per 1 ML
$0.214
HCPCS Q9963 · Jul 1, 2026 quarter · typically ASP + 6%
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- E-Z-EM Canada IncCanadaanalysis · manufacture
- analysis · api manufacture · label · pack
- Merck SLSpainanalysis · api manufacture · label · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- NDA011245
- TE code
- AA
- Approval date
- Jan 1, 1982
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
- Class II · TerminatedApr 13, 2022Mckesson Medical-Surgical Inc. Corporate Office — cGMP deviations: Temperature abuse
- Class II · TerminatedJun 21, 2013Bracco Diagnostics Inc — Presence of foreign substance: One lot of the product may contain black foreign particles
Manufacturers of diatrizoate meglumine and diatrizoate sodium (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bracco Diagnostics Inc | DIATRIZOATE MEGLUMINE 660 mg/mL; DIATRIZOATE SODIUM 100 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Gastrografin — NDC 00270-0445-35," retrieved September 3, 2026, https://drugdashboards.com/drug/00270044535.
Free to cite with attribution — see how the data is put together.